Posted on March 19th, 2019 by Moderator
Posted In: Director's Album - Photos, Uncategorized
Tags: art, Beyond the Diagnosis, giant axonal neuropathy, Patricia Weltin, Rare Disease Day
I hope this not supported by diversion of funds from improving diagnosis, treatment. I want failures redressed ASAP by productive medical investigation. Isn’t that the NIH’s mission? What Congress has appropriated the NIH our tax dollars for? Not PR spectacles.
Thanks for your comment.Beyond the Diagnosis is a non-profit organization. According to its website, all funding to support the Beyond the Diagnosis art exhibit comes from corporate or private patrons.
I’ve had the honor of viewing this exhibit at the Broad Institute while I was visiting the MIT campus to discuss our daughter’s rare disease with researchers. The portraits not only show each person’s beauty, they connect a living person to each rare disorder. These portraits have been exhibited in numerous research institutions where they inspire the people who carry out the work required to understand disease pathology, identify treatment targets and translate research into treatment.
Appointed the 16th Director of NIH by President Barack Obama and confirmed by the Senate. He was sworn in on August 17, 2009. On June 6, 2017. President Donald Trump announced his selection of Dr. Collins to continue to serve as the NIH Director.
Please join me tomorrow (9/24) at 12:10 pm ET on #NIH’s Facebook & Twitter for a live update on #COVID19 vaccine re… https://t.co/G6gC2Tp32I 16 hours ago
The fourth Phase 3 clinical trial for a #COVID19 vaccine has begun! Ad.26.COV2.S, developed by @JanssenUS & with tr… https://t.co/FZDqSpoQHd 22 hours ago
Rigorous clinical trials help us find safe, effective #COVID19 treatments. #NIH’s @ncats_nih_gov is expanding enrol… https://t.co/SwlFhkwPc7 1 day ago
Kendall Morgan, Ph.D.
If you have comments or questions not related to the current discussions, please direct them to Ask NIH.
You are encouraged to share your thoughts and ideas. Please review the NIH Comments Policy